Payer

Morgan Stanley analysts predict the weight loss drug market will hit $77 billion by 2030, MarketScreener reported July 21.

Most states oversee payers' requests for higher premium rates from members, and some states have additional oversight requirements, including oversight around the financial impact of payer-provider contract negotiations, according to a July 21 analysis from the National Conference of State…

A group of lawmakers is urging the Biden administration and Congress to do more to limit Medicare Advantage overpayments, misleading marketing and prior authorization denials. 

A bill aiming to reform the Medicare Advantage prior authorization process was included in a package of healthcare legislation that passed the House Ways and Means Committee and is headed to the full House for further consideration. 

Ten providers recently posted job listings seeking leaders in payer contracting and relations.

A system error caused BlueCross BlueShield of Tennessee to mail 2,688 letters to outdated addresses. 

Medicare Advantage enrollees who use supplemental benefits are more likely to live in areas with fewer resources, according to a report from the Elevance Health Public Policy Institute. 

Nine state Medicaid programs currently cover Wegovy, Novo Nordisk's high-priced weight loss drug, Bloomberg Law reported July 26. 

Aetna, Inland Empire Health Plan and Health Net will expand their reach on Covered California, the state's ACA exchange, in 2023. 

Better data sharing practices can improve value-based care arrangements, according to a new report from AHIP, the American Medical Association and the National Association of Accountable Care Organizations.